You are in: eMedicine Specialties > Radiology > BRAIN/SPINE SyringohydromyeliaArticle Last Updated: May 9, 2007AUTHOR AND EDITOR INFORMATIONAuthor: Farhood Saremi, MD, Professor of Radiology, University of California, Irvine College of Medicine; Director, Division of Cardiothoracic Imaging, Department of Radiological Sciences, University of California, Irvine Medical Center Farhood Saremi is a member of the following medical societies: American College of Radiology and Radiological Society of North America Coauthor(s): Chi-Shing Zee, MD, Chief of Neuroradiology, Professor, Departments of Radiology and Neurosurgery, University of Southern California School of Medicine; John L Go, MD, Assistant Professor, Department of Radiology, Section of Neuroradiology, Keck School of Medicine, University of Southern California Medical Center Editors: Lucien M Levy, MD, PhD, Director of Neuroradiology, Professor of Radiology, Department of Radiology, George Washington University Medical Center; Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand; Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute; James G Smirniotopoulos, MD, Professor of Radiology, Neurology, and Biomedical Informatics, Chairman, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences Author and Editor Disclosure Synonyms and related keywords: hydromyelia, syringomyelia, cord syrinx INTRODUCTIONBackgroundTubular cavitation of the spinal cord, along with associated progressive neurologic symptoms, has long attracted medical interest. An accumulation of cerebrospinal fluid (CSF) can lead to simple distention of the central canal of the spinal cord, lined by ependymal cells (ie, hydromyelia), or it can dissect into the surrounding white matter to form a paracentral cavity, in which case none of the cavity is lined by ependyma (ie, syringomyelia). In many, if not most, cases, both hydromyelia and syringomyelia are present (ie, syringohydromyelia). As the syringomyelic cavity expands, the initial hydromyelic cavity compresses, and the communication between the 2 cavities may atrophy and be lost. The distinction between hydromyelia and syringomyelia may be difficult even after a detailed histologic examination. In 1973, Barnett et al1 published a classic article on the etiology of syringomyelia. The authors classified syringohydromyelic cavities into 5 types:
In a study by Milhorat et al,2 the intramedullary cavities were classified into communicating, noncommunicating, and atrophic types to conform to the classification of the ventricular enlargements of the brain. Overall, the etiologies of communicating hydrocephalus include subarachnoid hemorrhage, meningitis, neoplastic seeding of the leptomeninges, and idiopathic causes. A model of the communicating type can be produced by injecting sclerosing agents into the cisterna magna. Obstruction of the basilar subarachnoid cisterns results in symmetric enlargement of the CSF cavities proximal to the blockage, including all 4 cerebral ventricles and the central canal of the spinal cord. Noncommunicating syringes are subdivided into 6 types, including:
Adhesive spinal arachnoiditis may develop postoperatively or after trauma; following pyogenic, tuberculous, or luetic (syphilitic) meningitis; or after bleeding into the subarachnoid space. Atrophic syringes, which occur with myelomalacia (following trauma or infarction), are associated with a reduction in the transverse dimensions of the spinal cord. Atrophic syringes are limited to a discrete area of myelomalacia in a manner similar to the porencephalic cysts that occur in some cases of encephalomalacia. Other associated findings include Klippel-Feil anomaly, basilar impression, scoliosis, craniovertebral fusion, and hydrocephalus. PathophysiologyConsiderable attention has been focused on the pathogenesis of syringes occurring with Chiari malformations. Gardner and McMurray3 originally proposed that obstruction of the outlets of the fourth ventricle causes the CSF pulse wave to be directed caudally, producing a "water hammer" effect that dilates the lumen of the central canal. Williams4 wrote that obstructions at the level of the foramen magnum produce a dissociation of pressure between the cranial and spinal CSF compartments. Fluid is "sucked" from the fourth ventricle into the central canal as a consequence of a relatively lower pressure caudal to the blockage. Other authors, while agreeing that a pressure gradient contributes to syrinx formation, have proposed that the CSF enters the central canal from the spinal subarachnoid space through the enlarged Virchow-Robin spaces as a consequence of increased intraspinal pressure. Hydrodynamic theories have been broadly applied to other types of syrinx formation. Valsalva maneuvers, such as sneezing, coughing, and straining, presumably accentuate the phenomenon by producing sudden changes in spinal venous volume and pressure. The progression of syringomyelia associated with Chiari I malformation was also attributed to the pulsatile action of the cerebellar tonsils5; however, the significance of this finding remains unclear, and this does not necessarily correlate with the presence or absence of symptoms. According to a theoretical model of pressure wave propagation in fluid-filled elastic tubes, the increased pulse pressure that may occur in a region of stenosis of the spinal subarachnoid space (an elastic jump) may be another contributory mechanism for the generation of syringes. Studies using magnetic resonance imaging (MRI) flow techniques have shown that abnormal global intracranial compliance may play an important role in the generation of syringomyelia and may be a useful parameter in estimating the outcome of decompression surgery in patients with Chiari I malformations. Basal arachnoiditis (chronic meningitis, subarachnoid hemorrhage, idiopathic origin) may be associated with communicating hydrocephalus. The restriction of CSF equilibration has been proposed as the responsible factor. Extramedullary lesions, such as chronically herniated discs, basilar impression, and intradural masses, may be associated with syringohydromyelia. In most patients, syringes are found at the lower border of the compressed segment of the spinal cord and are separated from the fourth ventricle by a syrinx-free segment. The location of syringes immediately below an extramedullary obstruction raises the possibility that extrinsic compression of the central canal contributes to dilatation of the lumen caudal to the blockage; however, since syringes are occasionally encountered at or above the level of the extramedullary tumors, the precise mechanism of syrinx formation in these cases is unclear. A distinctive feature of posttraumatic syringes is their tendency to extend rostrally from the level of the injury. Unless there are associated disturbances in the CSF dynamics caused by conditions such as arachnoid scarring or cord tethering, posttraumatic syringes may not be explained by conventional theories. With intramedullary tumors and infections, the most common cause of spinal cord cavitation is cystic degeneration of the primary neoplastic or infectious lesion. The necrotic process tends to begin centrally and can extend rostrally, caudally, or both ways. Factors independent of the tumor (in particular, disturbances of CSF and extracellular fluid flow) are postulated to play major roles in the pathogenesis of syrinx formation associated with intramedullary tumors. The same factors may apply in cases of intramedullary infection. At least 3 mechanisms have been proposed to account for cases of adhesive spinal arachnoiditis, including vascular compromise, CSF blockage, and fixation of the spinal cord from meningeal scarring. Focal scarring and spinal blockage may obstruct spinal CSF circulation and force CSF into the spinal cord via perivascular spaces. Circumferential fixation of the spinal cord may create an intrinsic negative pressure within the spinal cord, a process that may further promote the accumulation of fluid in the cord. FrequencyInternational
SexMales and females are equally affected. AgeSyringomyelia is usually encountered in adults but has occasionally occurred in infants. The youngest reported infant was aged 5 weeks. AnatomyWhen exposed at operation or autopsy, the spinal cord appears swollen and tense in the cervical region and may fill the spinal canal. Externally, the spinal cord appears normal, with no leptomeningeal thickening (idiopathic form). The syrinx is filled with a clear fluid that is usually similar in composition to CSF or is yellow with a high protein content. Clinical DetailsSince syringomyelia is associated with many pathogenetic factors, symptoms are apt to vary, and the classic syndrome of muscular atrophy of the upper extremities accompanied by dissociated sensory loss and long tract signs in the lower extremities is encountered infrequently (50%). The dissociated sensory changes typical of syringomyelia include loss of pain and temperature appreciation, with the preservation of touch and joint positions. Approximately 80% of patients complain of stiffness in the legs and weakness in the legs or hands. Pain is present in 50% of patients and often has a radicular component. Pain and neurologic complaints may be exacerbated by coughing and sneezing. Progressive scoliosis may be encountered and tends to be localized to the upper thoracic spine. Brainstem findings, including nystagmus, dysphagia, and lower nerve palsies, are present in a small number of patients. Neurogenic arthropathy (ie, Charcot joints) is an unusual event and occurs in fewer than 5% of patients with syringomyelia. Posttraumatic syringomyelia may develop after either severe or relatively minor spinal cord injury. Enlarging posttraumatic syringomyelia is manifested clinically by a progressive neurologic deficit that extends some distance above the initial site of injury. The clinical problem can develop from several months to many years after the initial injury. Preferred ExaminationMRI is the examination of choice. RADIOGRAPHFindingsPatients in whom syringomyelia is suggested by clinical criteria should have the diagnosis confirmed by radiographic investigation. Associated congenital anomalies include basilar impression and platybasia, Klippel-Feil deformity, atlanto-occipital fusion, and spina bifida occurring primarily at the C1 vertebra. Scoliosis, widening of the central spinal canal, and diastematomyelia are additional associated findings. Peripheral neuropathic joints or even neuropathic alteration of the spine itself may develop in long-standing cases of syringomyelia. Scoliosis associated with markedly destructive changes of shoulder joints should prompt a search for syringomyelia. The most common abnormal radiographic musculoskeletal findings are those of joint distention in dislocation, degeneration, and frank joint destruction. An atrophic form with resorption of the proximal humerus is described frequently in syringomyelia. The scoliosis in this category is a progressive change that results from the cord cavitation, associated loss of anterior horn cells, and perispinal muscular imbalance, ultimately leading to scoliosis as a secondary phenomenon. Degree of ConfidenceMRI findings are characteristic, and the diagnosis is straightforward. CT SCANFindingsMRI is the procedure of choice. MRIFindingsThe advent of MRI has revolutionized the diagnosis and follow-up imaging of syringohydromyelia. Not only is the disorder more common than previously recognized, but it can now be shown to occur in association with a wide variety of congenital and acquired lesions. With the use of MRI, classifying intramedullary cavities according to anatomic and pathologic types is possible.
Gadolinium-based contrast agents (gadopentetate dimeglumine [Magnevist], gadobenate dimeglumine [MultiHance], gadodiamide [Omniscan], gadoversetamide [OptiMARK], gadoteridol [ProHance]) have recently been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). For more information, see the eMedicine topic Nephrogenic Fibrosing Dermopathy. The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or MRA scans. As of late December 2006, the FDA had received reports of 90 such cases. Worldwide, over 200 cases have been reported, according to the FDA. NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble movingor straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness. For more information, see the FDA Public Health Advisory or Medscape. Degree of ConfidenceFindings are characteristic for the diagnosis of syringomyelia. INTERVENTIONSince syringomyelia is a complex pathologic disorder, its treatment is multifaceted and includes a variety of surgical options. Effective syrinx decompression has the potential to reverse neurologic deficits caused by raised intramedullary pressure, but it does not affect deficits caused by the pathologic abnormalities of spinal cord cavitation. Traditional surgical approaches are based on prevailing concepts of syringomyelia pathogenesis. Treatment of communicating syringomyelia and syringes associated with Chiari II malformation with hydrocephalus consists of placing a ventriculoperitoneal shunt. Decompressive surgery, including limited suboccipital craniectomy and C1 laminectomy with duraplasty, is generally considered the procedure of choice in syringes associated with Chiari I malformations. A significant improvement is observed in 50% of patients. An adjunct surgical approach to treating Chiari I malformation is syrinx shunting. Shunts to the spinal subarachnoid space are less reliable than shunts to the cerebellopontine angle cistern or to the peritoneal cavity. Other forms of treatment remain controversial, such as shunting of the fourth ventricle, plugging of the obex, and excision of the cerebellar tonsils. Patients who come to surgical attention late in the disease course and who have a rapid loss of neurologic function tend to do poorly. Since the time course of the neurologic change is typically long, a follow-up period of less than 5-10 years after surgery is of questionable value in assessing the final response to therapy. Initial treatment of syringes occurring with extramedullary lesions should consist of surgical excision of the primary lesion and decompression of the blockage/compression. Posttraumatic syringes can be treated using syringospinal, syringocisternal, or syringoperitoneal shunts. Posttraumatic cystic myelopathy can occur with or without the presence of the tethered cord syndrome. Detection and removal of the cause of a CSF flow abnormality, such as arachnoid scarring and/or cord untethering, with duraplasty to expand the subarachnoid space may be, in some cases, a more physiologically sound approach. In general, patients with posttraumatic syringomyelia respond favorably to surgery. Treatment of atrophic syringomyelia is limited to relieving symptoms related to the causal lesion. Operative findings that are associated with a more unsatisfactory result include the presence of dense basal cistern or spinal canal arachnoiditis. MULTIMEDIA
REFERENCES
Article Last Updated: May 9, 2007 | |||||||||||||||||||||||||||||||||||||||||||||||